I get the point that Dr. Dalton can’t speak in detail about his private companies until they are formally merged into UNVC, and I think most of us here understand that. SEC rules are strict and no one is asking him to cross that line.

But there’s a middle ground between saying nothing and disclosing non-public information. He can give formal investor updates in broad terms. Things like:
• Where UNVC stands today as a public company.
• General progress on its strategy without referencing private-company financials.
• Confirmation of priorities and what steps remain before a merger can even be considered.
• Any non-material milestones that show shareholders the company is still alive and moving forward.

These kinds of updates don’t violate SEC rules — many OTC companies provide them. They keep investors informed without revealing sensitive or non-public details.

What shareholders are asking for isn’t inside information, it’s basic communication. Years of silence broken only by LinkedIn comments isn’t enough for a publicly traded company. Even a short quarterly shareholder letter or a general status release would go a long way to build trust.

So while I respect that Dalton can’t discuss his private holdings until a merger is official, that doesn’t mean investors should be left entirely in the dark. A little more transparency, even at a general level, is both possible and overdue.